
Protara Therapeutics Inc (TARA)
NASDAQ
The current TARA market cap is 88.71M. The company's latest EPS is USD -1.9593 and P/E is -0.43.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -10.7M | -11.04M | -11.85M | -10.66M | -12.33M |
Net Income | -9.86M | -10.22M | -11.1M | -9.51M | -11.22M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -15.25M | -34.44M | -47.49M | -67.06M | -43.61M |
Net Income | -14.99M | -33.98M | -47.25M | -65.95M | -40.42M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 88.47M | 78.95M | 68.13M | 101.65M | 94.09M |
Total Liabilities | 11.51M | 10.63M | 9.73M | 9.6M | 12.3M |
Total Equity | 76.96M | 68.32M | 58.41M | 92.05M | 81.79M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 6.98M | 203.16M | 172.6M | 113.29M | 78.95M |
Total Liabilities | 583k | 3.91M | 10.68M | 11.21M | 10.63M |
Total Equity | 6.39M | 199.24M | 161.91M | 102.08M | 68.32M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -28.86M | -37.56M | -10.38M | -18.07M | -26.5M |
Investing | 38.59M | 53.11M | 23.1M | 26.05M | -3.35M |
Financing | -91k | -91k | -76k | 42.02M | 42.02M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -15.65M | -23.41M | -34.5M | -26.46M | -37.56M |
Investing | 2.48M | 2.84M | -98.19M | 14.95M | 53.11M |
Financing | N/A | 189.4M | -228k | -90k | -91k |
Market Cap | 88.71M |
Price to Earnings Ratio | -0.43 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.44 |
Price to Book Ratio | 0.25 |
Dividend Yield | - |
Shares Outstanding | 20.63M |
Average Volume (1 week) | 251.93k |
Average Volume (1 Month) | 261.25k |
52 Week Change | 49.31% |
52 Week High | 10.48 |
52 Week Low | 1.595 |
Spread (Intraday) | 0.42 (9.35%) |
Company Name | Protara Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://protaratx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.